Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1161/CIRCULATIONAHA.118.036846

Type

Journal article

Journal

Circulation

Publication Date

09/10/2018

Volume

138

Pages

1499 - 1501

Keywords

randomized trial, safety, statins, Biomarkers, Dyslipidemias, Evidence-Based Medicine, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipids, Muscular Diseases, Patient Safety, Randomized Controlled Trials as Topic, Risk Assessment, Risk Factors, Treatment Outcome